Zimmer Biomet Holdings (ZBH) Capital Expenditures (2009 - 2026)

Zimmer Biomet Holdings' Capital Expenditures history runs 18 years deep, the most recent figure standing at $36.3 million for Q1 2026.

• In Q1 2026, Capital Expenditures fell 18.61% year-over-year to $36.3 million; the TTM figure through Mar 2026 stood at $216.2 million (up 11.85% YoY), while the FY2025 annual figure was $224.5 million, up 10.16% from the prior year.
• Capital Expenditures was $36.3 million for Q1 2026 at Zimmer Biomet Holdings, down from $74.8 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $97.3 million in Q2 2023 to a low of $36.3 million in Q1 2026.
• Historically, Capital Expenditures has averaged $55.5 million across 5 years, with a median of $51.5 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Capital Expenditures jumped 137.9% in 2023, then plunged 47.21% in 2024.
• A 5-year view of Capital Expenditures shows it stood at $63.4 million in 2022, then slipped by 0.95% to $62.8 million in 2023, then decreased by 17.99% to $51.5 million in 2024, then soared by 45.24% to $74.8 million in 2025, then slumped by 51.47% to $36.3 million in 2026.
• The last three Capital Expenditures figures came in at $36.3 million (Q1 2026), $74.8 million (Q4 2025), and $55.0 million (Q3 2025), per Business Quant data.